Postoperative drug therapy to extend survival after coronary artery bypass grafting.
Roberts
C S
CS
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D003131:Combined Modality Therapy / Q000401:mortality; D001026:Coronary Artery Bypass / Q000401:mortality*; D003327:Coronary Disease / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male; D011182:Postoperative Care; D017035:Pravastatin / Q000627:therapeutic use; D015996:Survival Rate
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D017035:Pravastatin; D001241:Aspirin